Joseph Payne
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $750,000 | $1,691,000 |
| 2024 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $695,000 | $3,697,000 |
| 2023 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $698,000 | $4,892,500 |
| 2022 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $630,000 | $5,594,000 |
| 2021 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $600,000 | $960,000 |
| 2020 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $500,000 | $12,861,500 |
| 2019 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $450,000 | $1,165,818 |
| 2018 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $425,000 | $2,687,044 |
Earnings-call appearances
-
Arcturus Therapeutics Holdings Inc. Q1 FY2026 Earnings Call2026-05-07
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q4 FY2025 Earnings Call2026-03-03
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q3 FY2025 Earnings Call2025-11-10
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q2 FY2025 Earnings Call2025-08-11
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q4 FY2024 Earnings Call2025-03-06
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q3 FY2024 Earnings Call2024-11-07
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q1 FY2024 Earnings Call2024-05-08
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q3 FY2023 Earnings Call2023-11-14
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q2 FY2023 Earnings Call2023-08-07
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q1 FY2023 Earnings Call2023-05-09
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q4 FY2022 Earnings Call2023-03-28
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q3 FY2022 Earnings Call2022-11-09
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q2 FY2022 Earnings Call2022-08-09
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q1 FY2022 Earnings Call2022-05-09
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q4 FY2021 Earnings Call2022-02-28
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q3 FY2021 Earnings Call2021-11-08
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q2 FY2021 Earnings Call2021-08-09
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q1 FY2021 Earnings Call2021-05-10
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q4 FY2020 Earnings Call2021-03-01
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q3 FY2020 Earnings Call2020-11-09
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q2 FY2020 Earnings Call2020-08-10
Arcturus Therapeutics Holdings Inc. (ARCT)
-
Arcturus Therapeutics Holdings Inc. Q1 FY2020 Earnings Call2020-05-07
Arcturus Therapeutics Holdings Inc. (ARCT)